I have no idea what to make of that presentation. So, do we or do we not have the first to market Alzheimer test? Is he excited that we are going to finally see revenue from Lympro? Did they discover something better than Lympro? It sounded to me like it was the same presentaion we have heard over and over, except that version 1 was going to be the choice. I didn't hear any numbers that indicate that they achieved what the KOL's were looking for. This day was the reason for the delay in announcing in 2014? You all know i am a big supporter, but WTH was that? And so we wait some more. If there was excitement about the work they had acomplished, I sure didn't hear it. Sorry G, unless we are misunderstanding what you just presented I would say that was a huge failure. At least in my eyes. Did I miss something? Please feel free to comment.
dave
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links